Collaborative multicenter prognostication and staging system for cutaneous squamous cell carcinoma (COMPASS-SCC)
Journal of the American Academy of Dermatology · 2026-10
DOI: 10.1016/j.jaad.2026.09.104 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Academy of Dermatology, 2026-10. Verfasst von Kathryn T Shahwan und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The Ohio State University Medical Center, Columbus, Ohio. Electronic address: Kathryn.Shahwan@osumc.edu. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: The American Joint Committee on Cancer (AJCC8) and Brigham and Women's Hospital (BWH) are the most commonly used staging systems for cutaneous squamous cell carcinoma (CSCC). Both have limitations. OBJECTIVE: To develop a novel CSCC staging system (COMPASS-SCC) with improved performance. METHODS: This study utilized a retrospective CSCC database from 12 international centers. Univariable and multivariable Fine and Gray models assessed risk factors' impact on major poor outcomes (metastasis and disease specific death) for inclusion and weight in the staging system. Sensitivity, specificity, positive and negative predictive value, Area Under the Receiver Operating Characteristic curve, and Uno's c-index were calculated. RESULTS: 20,972 primary tumors were included. Diameter (1 point for ≥2 but 6 millimeters), differentiation (1 point for moderate, 2 points for poor), large-caliber perineural invasion (1 point), and lymphovascular invasion (1 point) were included in the system, with stages from T1 (0 points) to T4 (≥5 points). Sensitivity, negative predictive value, Area Under the Receiver Operating Characteristic curve, and Uno's c-index were significantly higher in COMPASS-SCC than in AJCC8 and BWH. LIMITATIONS: Retrospective design. CONCLUSION: COMPASS-SCC is a novel CSCC staging system with improved prognostic performance compared to AJCC8 and BWH.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, The Ohio State University Medical Center, Columbus, Ohio. Electronic address: Kathryn.Shahwan@osumc.edu.
- Department of Dermatology, The Ohio State University Medical Center, Columbus, Ohio.
- Department of Dermatology, New York University School of Medicine, New York, New York.
- Department of Biostatistics, University of Nebraska Medical Center, Omaha, Nebraska.
- Department of Data Science, Dana Farber Cancer Institute, Boston, Massachusetts.
- Center for Biostatistics, The Ohio State University Medical Center, Columbus, Ohio.
Zitieren
APA
Shahwan, K. T., Voller, L. M., Jairath, N. K., Zheng, C., Lotter, W., Nikahd, M., Hyer, M., Ruiz, E., Vidimos, A., Girardi, F. M., Brodland, D. G., Zitelli, J. A., Wysong, A., Carr, D. R., & Cutaneous Squamous Cell Carcinoma Database Working Group (2026). Collaborative multicenter prognostication and staging system for cutaneous squamous cell carcinoma (COMPASS-SCC). Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2026.09.104
Vancouver
Shahwan KT, Voller LM, Jairath NK, Zheng C, Lotter W, Nikahd M, et al. Collaborative multicenter prognostication and staging system for cutaneous squamous cell carcinoma (COMPASS-SCC). Journal of the American Academy of Dermatology. 2026. doi:10.1016/j.jaad.2026.09.104
BibTeX
@article{Shahwan2026,
author = {Shahwan, Kathryn T and Voller, Lindsey M and Jairath, Neil K and Zheng, Cheng and Lotter, William and Nikahd, Melica and Hyer, Madison and Ruiz, Emily and Vidimos, Allison and Girardi, Fabio Muradás and Brodland, David G and Zitelli, John A and Wysong, Ashley and Carr, David R and Cutaneous Squamous Cell Carcinoma Database Working Group, Cutaneous Squamous Cell Carcinoma Database Working Group},
title = {Collaborative multicenter prognostication and staging system for cutaneous squamous cell carcinoma (COMPASS-SCC)},
journal = {Journal of the American Academy of Dermatology},
year = {2026},
doi = {10.1016/j.jaad.2026.09.104}
}
EUVIMED